Table 1.

Correlation of the expression of miR-20a with clinicopathologic features.

Clinicopathologic features	No.	Relative expression of miR-20a a	p-value b
Gender			0.727
Male	18	0.72 (0.51–1.33)
Female	10	0.70 (0.52–1.02)
Site of tumor			0.810
Upper stomach	8	0.68 (0.52–1.00)
Middle stomach	6	0.70 (0.51–1.22)
Lower stomach	14	0.71 (0.51–1.32)
Differentiation			0.655
Poor	12	0.73 (0.59–1.33)
Moderate	16	0.72 (0.52–1.12)
Metastasis			0.003
N0	4	0.55 (0.51–0.61)
N1	5	0.62 (0.51–0.64)
N2	9	0.74 (0.52–1.09)
N3	9	0.92 (0.51–1.33)

^aMedian of relative expression;

^bMann-Whitney U test between two groups and Kruskall-Wallis test for three groups.